A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY,EFFICACY, AND TREATMENT REGIMEN OF ST266 IN SUBJECTS WITH MODERATE TO SEVEREPERIODONTITIS
Gum Disease Study
Sponsor: Noveome
Enrolling: Male and Female Patients
Study Length: 9 Months
Clinic Visits: 9
IRB Number: AAAQ7851
U.S. Govt. ID: NCT02761993
Contact: Romanita Celenti: 212-305-9308 / rsc1@columbia.edu
Additional Study Information: This study is for healthy subjects with gum (periodontal) disease. The purpose of this study is to study a new investigational topical medication applied to the gums that may improve the signs and symptoms of gym disease. The study requires you to come visit our clinic for approximately 9 evaluation visits and up to 29 treatments visits over a 9 month study period.
This study is closed
Investigator
Panos Papapanou, DDS, PhD
Do You Qualify?
Do you have gum (periodontal) disease? Yes No
Do you have at least 18 natural teeth? Yes No
Are you in good health? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Romanita Celenti
rsc1@columbia.edu
212-305-9308
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE